Centro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (50)

2024

  1. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure

  2. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve

    Circulation, Vol. 147, Núm. 1, pp. 47-65

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis

    Hepatology, Vol. 77, Núm. 3, pp. 874-887

  4. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2022

  1. Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680

  2. Extracellular vesicles from Listeria monocytogenes-infected dendritic cells alert the innate immune response

    Frontiers in Immunology, Vol. 13

  3. PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy

    Journal of Gastrointestinal Surgery, Vol. 26, Núm. 2, pp. 286-297

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  6. Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort

    International Journal of Cardiology, Vol. 367, pp. 90-98

  7. Targeting ERK3/MK5 complex for treatment of obesity and diabetes

    Biochemical and Biophysical Research Communications, Vol. 612, pp. 119-125

2021

  1. In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients

    EuroIntervention, Vol. 16, Núm. 17, pp. 1426-1433

  2. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

    Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  2. Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269

  3. Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism

    eLife, Vol. 9

  4. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation

    Journal of Allergy and Clinical Immunology, Vol. 145, Núm. 1, pp. 199-214.e11

2019

  1. Adiponectin accounts for gender differences in hepatocellular carcinoma incidence

    Journal of Experimental Medicine, Vol. 216, Núm. 5, pp. 1108-1119